Issue of Shares No 14

The ongoing issue of shares, No 14 is prolonged 2 weeks, until Januari 2, 2019

Extra Shareholders Meeting, December 4, 2018

At the meeting it was decided that Board should consist of 4 persons, Attorney Thomas Enckell, Attorney Jonas Gulliksson, Professor Henrik Thorlacius and CEO Anders Grönberg. The board was constituted as follows: Chairman Thomas Enckell, Board members Anders Grönberg, Henrik Thorlacius and Jonas Gulliksson. Issue of Shares No 14 The ongoing issue of shares, No […]

Hans Skalin awarded honorary doctorates by the Faculty of Medicine 2014

Long-standing and close relationships with medical research and development at Lund University characterizes this year’s three honorary doctorates. Read more Hans Skalin appointed in 1986 as director to Mrs. Berta Kamprad’s Foundation for Cancer Research that preferably supports cancer research related to the oncology clinic in Lund. The genuine interest and commitment that Hans Skalin has […]

Invitation to subscribe for shares in CarpoNovum AB, January – March 2014

In April 2013 a private placement among existing shareholders was fully subscribed. The subscription period was closed Friday 26th April 2013. The raised gross proceeds were 6.4 MSEK (745.600 EUR). This placement, among existing shareholders, was to provide short term financing until suitable new investors have been identified and these new investors have finalized their […]

Mr Michael Parker, a new member of the advisory board of CarpoNovum (2012-03-13)

Mr Michael Parker, a new member of the advisory board of CarpoNovum (2012-03-13) Michael Parker has joined CarpoNovum, as a member in the advisory board, in our efforts to make CREX to the most wanted method used to anastomose colon to colon and colon to rectum. CarpoNovum are of course very proud to have him […]